IBM vs. ABBV
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IBM or ABBV.
|5Y Return (Ann)||4.41%||14.80%|
|10Y Return (Ann)||1.76%||17.25%|
|Daily Std Dev||18.80%||21.51%|
|Gross Profit (TTM)||$32.69B||$41.53B|
The correlation between IBM and ABBV is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
IBM vs. ABBV - Performance Comparison
In the year-to-date period, IBM achieves a 3.35% return, which is significantly higher than ABBV's -4.99% return. Over the past 10 years, IBM has underperformed ABBV with an annualized return of 1.76%, while ABBV has yielded a comparatively higher 17.25% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
IBM vs. ABBV - Dividend Comparison
IBM's dividend yield for the trailing twelve months is around 4.72%, more than ABBV's 3.92% yield.
IBM vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for International Business Machines Corporation (IBM) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
IBM vs. ABBV - Drawdown Comparison
The maximum IBM drawdown for the period was -17.61%, roughly equal to the maximum ABBV drawdown of -20.66%. The drawdown chart below compares losses from any high point along the way for IBM and ABBV
IBM vs. ABBV - Volatility Comparison
The current volatility for International Business Machines Corporation (IBM) is 4.63%, while AbbVie Inc. (ABBV) has a volatility of 4.89%. This indicates that IBM experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.